UA103885C2 - Immunogenic streptococcus proteins - Google Patents
Immunogenic streptococcus proteinsInfo
- Publication number
- UA103885C2 UA103885C2 UAA201002376A UAA201002376A UA103885C2 UA 103885 C2 UA103885 C2 UA 103885C2 UA A201002376 A UAA201002376 A UA A201002376A UA A201002376 A UAA201002376 A UA A201002376A UA 103885 C2 UA103885 C2 UA 103885C2
- Authority
- UA
- Ukraine
- Prior art keywords
- proteins
- immunogenic
- streptococcus
- eliciting
- immune response
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 6
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 230000002163 immunogen Effects 0.000 title abstract 4
- 241000194017 Streptococcus Species 0.000 title abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 241000194054 Streptococcus uberis Species 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 2
- 229940115922 streptococcus uberis Drugs 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Communicable Diseases (AREA)
- Pregnancy & Childbirth (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07113844A EP2023143A1 (en) | 2007-08-06 | 2007-08-06 | Immunogenic streptococcus proteins |
| PCT/NL2008/050537 WO2009020391A1 (en) | 2007-08-06 | 2008-08-05 | Immunogenic streptococcus proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA103885C2 true UA103885C2 (en) | 2013-12-10 |
Family
ID=38890252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201002376A UA103885C2 (en) | 2007-08-06 | 2008-08-05 | Immunogenic streptococcus proteins |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20100297183A1 (OSRAM) |
| EP (3) | EP2023143A1 (OSRAM) |
| JP (2) | JP5462164B2 (OSRAM) |
| KR (1) | KR20100063706A (OSRAM) |
| CN (1) | CN101821627A (OSRAM) |
| AR (1) | AR067830A1 (OSRAM) |
| AU (1) | AU2008284491A1 (OSRAM) |
| BR (1) | BRPI0815604A2 (OSRAM) |
| CA (1) | CA2695721A1 (OSRAM) |
| CL (1) | CL2008002320A1 (OSRAM) |
| CO (1) | CO6270172A2 (OSRAM) |
| DK (1) | DK2183597T3 (OSRAM) |
| ES (1) | ES2432407T3 (OSRAM) |
| MX (1) | MX2010001482A (OSRAM) |
| RU (1) | RU2518315C2 (OSRAM) |
| TW (1) | TW200911999A (OSRAM) |
| UA (1) | UA103885C2 (OSRAM) |
| WO (1) | WO2009020391A1 (OSRAM) |
| ZA (1) | ZA201000806B (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1098980B1 (en) | 1998-07-22 | 2014-09-03 | Stichting Dienst Landbouwkundig Onderzoek | Streptococcus suis vaccines and diagnostic tests |
| ATE507238T1 (de) * | 2001-02-02 | 2011-05-15 | Stichting Dienst Landbouwkundi | Umwelt-regulierte gene, welche an der virulenz von streptococcus suis beteiligt sind |
| GB0818231D0 (en) | 2008-10-06 | 2008-11-12 | Univ Nottingham | Composition |
| WO2015042369A2 (en) * | 2013-09-19 | 2015-03-26 | Zoetis Llc | Oil-based adjuvants |
| US20170369529A1 (en) * | 2014-12-22 | 2017-12-28 | Hoffmann-La Roche Inc. | Cell penetrating peptides |
| CA3001433A1 (en) | 2015-10-21 | 2017-04-27 | Minervax Aps | Immunogenic fusion protein |
| US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
| RU2685957C2 (ru) * | 2016-12-28 | 2019-04-23 | Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") | Химерный рекомбинантный белок, обладающий протективными свойствами в отношении Streptococcus pyogenes |
| CA3196872A1 (en) * | 2020-12-23 | 2022-06-30 | Chan Zuckerberg Biohub, Inc. | Bacteria-engineered to elicit antigen-specific t cells |
| CN112773891B (zh) * | 2021-02-01 | 2022-03-25 | 北部湾大学 | 卵形鲳鲹源无乳链球菌dna疫苗及其制备方法和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283507A (en) | 1990-12-20 | 1994-02-01 | General Electric Company | Regenerative braking protection for an electrically-propelled traction vehicle |
| NL9100510A (nl) * | 1991-03-21 | 1992-10-16 | Centraal Diergeneeskundig Inst | Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens. |
| IT1251435B (it) | 1991-09-04 | 1995-05-09 | Sclavo Spa | Vettore genetico per la integrazione multipla stabile di sequenze di dna nel genoma dei lieviti kluyveromyces lactis e saccharomyces cerevisiae e plasmidi che lo contengono. |
| US5928900A (en) * | 1993-09-01 | 1999-07-27 | The Rockefeller University | Bacterial exported proteins and acellular vaccines based thereon |
| EP0804582A1 (en) * | 1994-05-16 | 1997-11-05 | The Uab Research Foundation | $i(STREPTOCOCCUS PNEUMONIAE) CAPSULAR POLYSACCHARIDE GENES AND FLANKING REGIONS |
| US5681570A (en) * | 1995-01-12 | 1997-10-28 | Connaught Laboratories Limited | Immunogenic conjugate molecules |
| EP0750042A1 (fr) * | 1995-06-20 | 1996-12-27 | Societe Des Produits Nestle S.A. | Bactéries lactiques produisant des exopolysaccharides |
| AU738649B2 (en) | 1996-04-26 | 2001-09-20 | Rijksuniversiteit Te Leiden | Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| US6800744B1 (en) * | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| EP1098980B1 (en) * | 1998-07-22 | 2014-09-03 | Stichting Dienst Landbouwkundig Onderzoek | Streptococcus suis vaccines and diagnostic tests |
| US6582706B1 (en) * | 1998-12-21 | 2003-06-24 | Medimmune, Inc. | Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS |
| WO2000077178A1 (en) * | 1999-06-16 | 2000-12-21 | Boston Biomedical Research Institute | IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO |
| DE60136356D1 (de) * | 2000-06-12 | 2008-12-11 | Univ Saskatchewan | Chimäres GapC Protein aus Streptococcus und dessen Verwendung zur Impfung und Diagnostik |
| EP1205552A1 (en) * | 2000-11-09 | 2002-05-15 | ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. | Virulence of streptococci, involving ORFs from Streptococcus suis |
| ATE507238T1 (de) * | 2001-02-02 | 2011-05-15 | Stichting Dienst Landbouwkundi | Umwelt-regulierte gene, welche an der virulenz von streptococcus suis beteiligt sind |
| BR0316635A (pt) * | 2002-11-26 | 2005-10-11 | Univ Tennessee Res Foundation | Molécula de aderência de streptococcus uberis |
| EP1590368B1 (en) * | 2003-01-27 | 2014-02-26 | Københavns Universitet | Compounds useful in the diagnosis and treatment of pregnancy-associated malaria |
| US20080175856A1 (en) * | 2003-05-30 | 2008-07-24 | Intercell Ag | Enterococcus Antigens |
| WO2006048763A1 (en) * | 2004-11-05 | 2006-05-11 | Pharmacia & Upjohn Company Llc | Anti-bacterial vaccine compositions |
| SI2029173T1 (sl) * | 2006-06-26 | 2016-12-30 | Macrogenics, Inc. | Protitelesa, specifična za Fc RIIB, in postopki za njihovo uporabo |
-
2007
- 2007-08-06 EP EP07113844A patent/EP2023143A1/en not_active Withdrawn
-
2008
- 2008-08-05 CN CN200880110303A patent/CN101821627A/zh active Pending
- 2008-08-05 UA UAA201002376A patent/UA103885C2/ru unknown
- 2008-08-05 ES ES08793829T patent/ES2432407T3/es active Active
- 2008-08-05 EP EP13170976.8A patent/EP2660604A3/en not_active Withdrawn
- 2008-08-05 JP JP2010519882A patent/JP5462164B2/ja not_active Expired - Fee Related
- 2008-08-05 KR KR1020107004959A patent/KR20100063706A/ko not_active Ceased
- 2008-08-05 MX MX2010001482A patent/MX2010001482A/es active IP Right Grant
- 2008-08-05 CA CA2695721A patent/CA2695721A1/en not_active Abandoned
- 2008-08-05 US US12/733,159 patent/US20100297183A1/en not_active Abandoned
- 2008-08-05 DK DK08793829.6T patent/DK2183597T3/da active
- 2008-08-05 BR BRPI0815604-2A2A patent/BRPI0815604A2/pt not_active IP Right Cessation
- 2008-08-05 RU RU2010107878/15A patent/RU2518315C2/ru not_active IP Right Cessation
- 2008-08-05 EP EP08793829.6A patent/EP2183597B1/en active Active
- 2008-08-05 WO PCT/NL2008/050537 patent/WO2009020391A1/en not_active Ceased
- 2008-08-05 AU AU2008284491A patent/AU2008284491A1/en not_active Abandoned
- 2008-08-06 CL CL2008002320A patent/CL2008002320A1/es unknown
- 2008-08-06 TW TW097129912A patent/TW200911999A/zh unknown
- 2008-08-07 AR ARP080103446A patent/AR067830A1/es unknown
-
2010
- 2010-02-03 ZA ZA201000806A patent/ZA201000806B/xx unknown
- 2010-03-03 CO CO10025154A patent/CO6270172A2/es not_active Application Discontinuation
-
2014
- 2014-01-16 JP JP2014006098A patent/JP2014095721A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0815604A2 (pt) | 2015-03-03 |
| RU2518315C2 (ru) | 2014-06-10 |
| EP2023143A1 (en) | 2009-02-11 |
| MX2010001482A (es) | 2010-03-01 |
| EP2660604A2 (en) | 2013-11-06 |
| CN101821627A (zh) | 2010-09-01 |
| JP2010535500A (ja) | 2010-11-25 |
| CA2695721A1 (en) | 2009-02-12 |
| AR067830A1 (es) | 2009-10-21 |
| KR20100063706A (ko) | 2010-06-11 |
| US20100297183A1 (en) | 2010-11-25 |
| DK2183597T3 (da) | 2013-10-14 |
| JP5462164B2 (ja) | 2014-04-02 |
| EP2183597A1 (en) | 2010-05-12 |
| TW200911999A (en) | 2009-03-16 |
| ZA201000806B (en) | 2010-10-27 |
| CO6270172A2 (es) | 2011-04-20 |
| EP2183597B1 (en) | 2013-07-24 |
| ES2432407T3 (es) | 2013-12-03 |
| RU2010107878A (ru) | 2011-09-20 |
| JP2014095721A (ja) | 2014-05-22 |
| WO2009020391A1 (en) | 2009-02-12 |
| CL2008002320A1 (es) | 2009-09-25 |
| AU2008284491A1 (en) | 2009-02-12 |
| EP2660604A3 (en) | 2014-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA103885C2 (en) | Immunogenic streptococcus proteins | |
| BRPI0707154B8 (pt) | composição de vacina | |
| EP1917033A4 (en) | VIRUS LIKE PARTICLES AS PARAMYXOVIRUS VACCINES | |
| WO2007106476A3 (en) | Compositions and methods for enhancing the immunogenicity of antigens | |
| WO2014009438A3 (en) | Mycobacterial antigen vaccine | |
| WO2008127179A8 (en) | Fusion protein vaccine | |
| WO2012018907A3 (en) | Polypeptides for treating and/or limiting influenza infection | |
| DK1586646T3 (da) | Lawsonia intracellularis-vaccine | |
| DK2054431T3 (da) | Konformere af bakterielle adhæsiner | |
| WO2008137881A3 (en) | Ehrlichia ewingii proteins, nucleic acids, and methods of their use | |
| WO2005070958A3 (en) | Lawsonia intracellularis subunit vaccines | |
| EP2251035A3 (en) | New virulence factors of Streptococcus pneumoniae | |
| WO2009009039A3 (en) | Compositions containing full-length l1r nucleic acid and endoplasmic reticulum targeting sequence | |
| WO2005026200A3 (en) | Lawsonia intracellularis subunit vaccine | |
| WO2003095480A3 (en) | Brachyspira hyodysenteriae vaccine | |
| WO2013138259A3 (en) | Polypeptides for treating and/or limiting influenza infection | |
| WO2004007726A3 (en) | Brachyspira hyodysenteriae vaccine | |
| WO2010046778A3 (en) | Novel shigella frotein antigens and methods | |
| WO2008002548A3 (en) | Novel human acidic mammalian chitinase and use thereof | |
| WO2006113782A3 (en) | Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof | |
| WO2005026199A3 (en) | Piroplasmid vaccine | |
| WO2008076490A3 (en) | Histophilus somni antigens, compositions and methods of use | |
| TH127963A (th) | โปรตีนของ Streptococcus ที่ก่อภูมิคุ้มกัน | |
| Ruan et al. | Identification on the immunogenic activity of recombinant rLTB/CTB-LipL41/1 to Leptospira interrogans and detection of lipL41 gene with its production | |
| HK1158087A (en) | New virulence factors of streptococcus pneumoniae |